House Bill 1375 - EFFECTIVE Act

Purpose and Summary

Chamber: House

Introduced date: 2023-03-03

Recent Activity

Referred to the Subcommittee on Health.

Alternative Names

EFFECTIVE Act

EFFECTIVE Act

Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act

To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.

Associated Legislation

undefined

Policy Areas

Health

Potential Impact

Sponsors and Supporters

Rep. Trone, David J. [D-MD-6]

Cosponsors and Supporters

undefined

Committees and Subcommittees

Energy and Commerce Committee

Health Subcommittee

Variations and Revisions

EFFECTIVE Act

12/15/2023, 3:55 PM
Referred to the Subcommittee on Health.
Congress
118
Number
HR - 1375
Introduced on
2023-03-03
# Amendments
0
Sponsors
+5

Variations and Revisions

3/3/2023
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the Subcommittee on Health.
Alternative Names
Official Title as IntroducedTo allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
Policy Areas
Health

Comments

Recent Activity

Latest Action3/10/2023
Referred to the Subcommittee on Health.